Identify appropriate patients to refer for a genetic cancer risk assessment (GCRA). |
|
|
|
|
|
Explain the GCRA process and recognize the changing landscape of genetic testing – syndrome-driven versus multi-gene panels. |
|
|
|
|
|
Summarize the benefits and limitations of surveillance and risk management options for cancer predisposition syndrome. |
|
|
|
|
|